Novo Nordisk A/S Class B (0QIU) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Sep 2025 07:01 AM
GNW
Novo Nordisk to present new semaglutide data ...
31 Aug 2025 08:09 AM
GNW
Novo Nordisk’s Wegovy® cuts risk of heart att...
20 Aug 2025 02:30 PM
GNW
Novo Nordisk to present Wegovy® and Ozempic® ...
15 Aug 2025 10:23 PM
GNW
Novo Nordisk A/S: Wegovy® approved in the US ...
06 Aug 2025 06:30 AM
GNW
Novo Nordisk's sales increased by 16% in Dani...
29 Jul 2025 12:35 PM
GNW
Maziar Mike Doustdar appointed as president a...
29 Jul 2025 12:01 PM
GNW
Novo Nordisk lowers sales and operating profi...
25 Jul 2025 11:47 AM
GNW
European regulatory authority adopts positive...
23 Jun 2025 07:36 PM
GNW
Novo Nordisk A/S: Ozempic® receives EU recomm...
22 Jun 2025 08:35 PM
GNW
Novo Nordisk A/S: Mim8 prophylaxis treatment ...
22 Jun 2025 02:00 PM
GNW
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg d...
21 Jun 2025 12:38 AM
GNW
Novo Nordisk: Higher dose of Wegovy® provided...
21 Jun 2025 12:34 AM
GNW
Novo Nordisk’s subcutaneous and oral amycreti...
12 Jun 2025 06:06 PM
GNW
Novo Nordisk to advance subcutaneous and oral...
10 Jun 2025 01:00 PM
GNW
ADA 2025: Novo Nordisk highlights strong port...
16 May 2025 12:01 PM
GNW
Novo Nordisk A/S: Lars Fruergaard Jørgensen t...
14 May 2025 11:59 AM
GNW
Novo Nordisk A/S: Septerna and Novo Nordisk t...
12 May 2025 07:01 AM
GNW
Novo Nordisk A/S: Once-weekly Sogroya® (somap...
07 May 2025 06:30 AM
GNW
Novo Nordisk's sales increased by 19% in Dani...
03 Apr 2025 07:00 AM
GNW
Novo Nordisk announces changes in Executive M...
29 Mar 2025 06:33 PM
GNW
Novo Nordisk A/S: Rybelsus® (oral semaglutide...
29 Mar 2025 02:33 PM
GNW
Ozempic® (once-weekly semaglutide 1.0 mg) sho...
27 Mar 2025 03:16 PM
GNW
Resolutions from the Annual General Meeting o...
24 Mar 2025 10:01 AM
GNW
The United Laboratories and Novo Nordisk anno...
10 Mar 2025 10:23 AM
GNW
Novo Nordisk A/S: CagriSema demonstrates supe...
27 Feb 2025 02:03 PM
GNW
Novo Nordisk A/S: Notice for the Annual Gener...
07 Feb 2025 07:45 AM
GNW
Novo Nordisk A/S: Once-weekly Mim8 is well-to...
05 Feb 2025 12:36 PM
GNW
Novo Nordisk files annual report with the SEC
05 Feb 2025 06:30 AM
GNW
Novo Nordisk's sales increased by 25% in Dani...
24 Jan 2025 10:19 AM
GNW
Novo Nordisk successfully completes phase 1b/...
17 Jan 2025 12:11 PM
GNW
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. ach...
08 Jan 2025 11:30 AM
GNW
Valo Health and Novo Nordisk expand collabora...
20 Dec 2024 10:41 AM
GNW
Novo Nordisk A/S: CagriSema demonstrates supe...
18 Dec 2024 01:59 PM
GNW
The acquisition of Catalent by Novo Holdings,...
16 Dec 2024 06:29 AM
GNW
Novo Nordisk invests DKK 8.5 billion in new p...
14 Dec 2024 05:08 AM
GNW
Novo Nordisk A/S: The acquisition of Catalent...
12 Dec 2024 01:47 PM
GNW
Novo Nordisk A/S: European regulatory authori...
06 Dec 2024 06:10 PM
GNW
The European Commission approves the acquisit...
06 Nov 2024 06:30 AM
GNW
Novo Nordisk's sales increased by 23% in Dani...
01 Nov 2024 12:13 PM
GNW
Novo Nordisk A/S: Semaglutide 2.4 mg demonstr...
21 Oct 2024 10:26 AM
GNW
Novo Nordisk A/S: Oral semaglutide demonstrat...
18 Oct 2024 10:32 AM
GNW
Novo Nordisk A/S: Alhemo® recommended for Eur...
08 Oct 2024 09:00 AM
GNW
Novo Nordisk launches new initiative to preve...
20 Sep 2024 01:43 PM
GNW
Novo Nordisk A/S: Monlunabant phase 2a trial ...
19 Sep 2024 08:10 PM
GNW
Novo Nordisk A/S: Wegovy® recommended by the ...
07 Aug 2024 06:30 AM
GNW
Novo Nordisk's sales increased by 24% in Dani...
25 Jul 2024 04:08 PM
GNW
European regulatory authority adopts a positi...
10 Jul 2024 10:45 PM
GNW
Novo Nordisk receives Complete Response Lette...
26 Jun 2024 03:50 PM
GNW
Novo Nordisk stops the ocedurenone CLARION-CK...
24 Jun 2024 07:16 PM
GNW
Novo Nordisk announces 4.1 billion USD invest...
UK 100

Latest directors dealings